Zomedica(ZOMDF)
$0.10-0.00 (-4.85%)
ZOMDF
Zomedica financials statements
$0.10
At close:-0.00 (-4.85%)
Want to see ZOMDF full AI Analyst Report?
Zomedica (ZOMDF) Ratios
4,811 Followers
Zomedica Ratios
ZOMDF's free cash flow for Q3 2025 was $-5.88M. For the 2025 fiscal year, ZOMDF's free cash flow was decreased by $-1.09M and operating cash flow was $-4.80M. See a summary of the company’s cash flow.
| Ratios | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 11.06 | 15.81 | 46.18 | 30.99 | 0.87 |
| Quick Ratio | 10.49 | 15.46 | 45.52 | 30.99 | 0.87 |
| Cash Ratio | 1.43 | 3.51 | 44.92 | 30.56 | 0.24 |
| Solvency Ratio | -2.14 | -1.06 | -1.81 | -1.09 | -9.12 |
| Operating Cash Flow Ratio | -1.77 | -1.49 | -3.29 | -8.00 | -7.49 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -18.21 | -34.42 | -20.82 | 0.00 |
| Net Current Asset Value | $ 86.70M | $ 111.28M | $ 190.89M | $ 47.79M | $ -280.74K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.01 | 0.00 | 0.03 | 0.00 |
| Debt-to-Equity Ratio | 0.01 | 0.01 | 0.01 | 0.04 | 0.00 |
| Debt-to-Capital Ratio | 0.01 | 0.01 | 0.01 | 0.04 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.05 | 1.05 | 1.04 | 1.30 | 2.00 |
| Debt Service Coverage Ratio | -160.32 | -20.21 | -40.97 | -20.99 | -1037.98 |
| Interest Coverage Ratio | -180.53 | -21923.00 | -3530.56 | -22902.98 | -1078.87 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Net Debt to EBITDA | 0.35 | 1.67 | 9.89 | 3.67 | 0.03 |
| Profitability Margins | |||||
| Gross Profit Margin | 68.76% | 72.12% | 73.89% | 0.00% | 0.00% |
| EBIT Margin | -141.69% | -102.38% | -501.10% | 0.00% | 0.00% |
| EBITDA Margin | -116.68% | -81.02% | -473.51% | 0.00% | 0.00% |
| Operating Profit Margin | -125.43% | -115.81% | -517.14% | 0.00% | 0.00% |
| Pretax Profit Margin | -142.38% | -102.38% | -501.22% | 0.00% | 0.00% |
| Net Profit Margin | -137.10% | -89.88% | -444.78% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -137.10% | -89.88% | -444.80% | 0.00% | 0.00% |
| Net Income Per EBT | 96.29% | 87.79% | 88.74% | 100.06% | 100.19% |
| EBT Per EBIT | 113.51% | 88.40% | 96.92% | 100.88% | 100.00% |
| Return on Assets (ROA) | -13.64% | -6.09% | -6.56% | -25.58% | -473.88% |
| Return on Equity (ROE) | -14.39% | -6.36% | -6.79% | -33.14% | -945.96% |
| Return on Capital Employed (ROCE) | -12.94% | -8.07% | -7.74% | -26.15% | -944.15% |
| Return on Invested Capital (ROIC) | -12.41% | -7.05% | -6.85% | -25.75% | -945.97% |
| Return on Tangible Assets | -25.34% | -9.79% | -9.03% | -25.73% | -544.63% |
| Earnings Yield | -17.60% | -10.65% | -6.27% | -20.13% | -56.34% |
| Efficiency Ratios | |||||
| Receivables Turnover | 11.46 | 10.16 | 5.40 | 0.00 | 0.00 |
| Payables Turnover | 1.03 | 0.79 | 0.33 | 0.42 | 0.38 |
| Inventory Turnover | 1.54 | 1.92 | 0.38 | 0.00 | 0.00 |
| Fixed Asset Turnover | 1.00 | 2.07 | 1.64 | 0.00 | 0.00 |
| Asset Turnover | 0.10 | 0.07 | 0.01 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.24 | 0.12 | 0.03 | 0.00 | 0.00 |
| Cash Conversion Cycle | -86.21 | -237.36 | -59.93 | -859.87 | -967.41 |
| Days of Sales Outstanding | 31.85 | 35.94 | 67.60 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 237.66 | 189.90 | 963.36 | 0.00 | 0.00 |
| Days of Payables Outstanding | 355.72 | 463.20 | 1090.89 | 859.87 | 967.41 |
| Operating Cycle | 269.51 | 225.84 | 1030.96 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.02 | -0.01 | -0.01 | -0.04 | -0.15 |
| Free Cash Flow Per Share | -0.02 | -0.01 | -0.02 | -0.04 | -0.15 |
| Dividend Paid and CapEx Coverage Ratio | -3.44 | -11.37 | -27.13 | -966.97 | -22.76 |
| Capital Expenditure Coverage Ratio | -3.44 | -11.37 | -27.13 | -966.97 | -22.76 |
| Operating Cash Flow Coverage Ratio | -5.85 | -6.71 | -10.35 | -8.69 | 0.00 |
| Operating Cash Flow to Sales Ratio | -0.63 | -0.62 | -3.45 | 0.00 | 0.00 |
| Free Cash Flow Yield | -10.51% | -7.95% | -5.05% | -19.34% | -46.39% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -5.68 | -9.39 | -15.95 | -4.97 | -1.78 |
| Price-to-Sales (P/S) Ratio | 7.79 | 8.44 | 70.93 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.82 | 0.60 | 1.08 | 1.65 | 16.79 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -9.51 | -12.58 | -19.81 | -5.17 | -2.16 |
| Price-to-Operating Cash Flow Ratio | -12.28 | -13.69 | -20.54 | -5.18 | -2.25 |
| Price-to-Earnings Growth (PEG) Ratio | -0.06 | 1.00 | 0.27 | 0.07 | -0.32 |
| Enterprise Value Multiple | -6.33 | -8.74 | -5.09 | -1.46 | -1.83 |
| Enterprise Value | 185.96M | 134.07M | 99.60M | 23.92M | 34.67M |
| EV to EBITDA | -6.33 | -8.74 | -5.09 | -1.46 | -1.83 |
| EV to Sales | 7.38 | 7.08 | 24.10 | 0.00 | 0.00 |
| EV to Free Cash Flow | -9.02 | -10.56 | -6.73 | -1.47 | -2.12 |
| EV to Operating Cash Flow | -11.64 | -11.49 | -6.98 | -1.47 | -2.22 |
| Tangible Book Value Per Share | 0.13 | 0.16 | 0.20 | 0.14 | 0.01 |
| Shareholders’ Equity Per Share | 0.24 | 0.27 | 0.28 | 0.14 | 0.02 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.04 | 0.12 | 0.11 | -0.00 | -0.00 |
| Revenue Per Share | 0.03 | 0.02 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.04 | -0.02 | -0.02 | -0.05 | -0.19 |
| Tax Burden | 0.96 | 0.88 | 0.89 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.23 | 0.14 | 0.40 | 0.00 | 0.00 |
| SG&A to Revenue | 1.15 | 1.21 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.25 | 0.42 | 1.72 | 0.00 | 0.00 |
| Income Quality | 0.46 | 0.69 | 0.78 | 0.96 | 0.79 |
Currency in USD

